Zhe Jiang Dayang Biotech Group Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Zhe Jiang Dayang Biotech Group has a total shareholder equity of CN¥1.0B and total debt of CN¥338.6M, which brings its debt-to-equity ratio to 32.9%. Its total assets and total liabilities are CN¥1.6B and CN¥584.3M respectively. Zhe Jiang Dayang Biotech Group's EBIT is CN¥74.6M making its interest coverage ratio -132.8. It has cash and short-term investments of CN¥377.8M.
Anahtar bilgiler
32.9%
Borç/özkaynak oranı
CN¥338.57m
Borç
| Faiz karşılama oranı | -132.8x |
| Nakit | CN¥377.82m |
| Eşitlik | CN¥1.03b |
| Toplam yükümlülükler | CN¥584.35m |
| Toplam varlıklar | CN¥1.61b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 003017's short term assets (CN¥667.1M) exceed its short term liabilities (CN¥549.8M).
Uzun Vadeli Yükümlülükler: 003017's short term assets (CN¥667.1M) exceed its long term liabilities (CN¥34.5M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 003017 has more cash than its total debt.
Borcun Azaltılması: 003017's debt to equity ratio has increased from 6.4% to 32.9% over the past 5 years.
Borç Kapsamı: 003017's debt is well covered by operating cash flow (48.8%).
Faiz Kapsamı: 003017 earns more interest than it pays, so coverage of interest payments is not a concern.